Skip to main content
Approval for open phase II study
ULB Belgium’s ethical commitee has approved the protocol for an open phase II study of standard treatments in combination
Interest to use our technology for other cancers
Based on the visibility of preliminary results for GBM, independent groups expressed their strong interest to use the technology for other cancers.
for more details.